pCW57.1 ISCU D71A
(Plasmid
#169880)
-
PurposeExpresses ISCU iron-sulfur cluster trapping mutant (dominant negative)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 169880 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCW57.1
- Backbone size w/o insert (bp) 9354
- Total vector size (bp) 9859
-
Modifications to backbonePolylinker altered from original plasmid
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameISCU
-
Alt nameIron-Sulfur Cluster Assembly Enzyme
-
SpeciesH. sapiens (human), Synthetic
-
Insert Size (bp)504
-
MutationCodon Optimized, D71A iron-sulfur cluster trapping mutation, dominant negative
-
Entrez GeneISCU (a.k.a. 2310020H20Rik, HML, ISU2, NIFU, NIFUN, hnifU)
- Promoter TRE
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer LNCX (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCW57.1 ISCU D71A was a gift from Richard Possemato (Addgene plasmid # 169880 ; http://n2t.net/addgene:169880 ; RRID:Addgene_169880) -
For your References section:
Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5. Terzi EM, Sviderskiy VO, Alvarez SW, Whiten GC, Possemato R. Sci Adv. 2021 May 26;7(22). pii: 7/22/eabg4302. doi: 10.1126/sciadv.abg4302. Print 2021 May. 10.1126/sciadv.abg4302 PubMed 34039609